Analysts See $0.01 EPS for CBIZ, Inc. (CBZ)

January 23, 2018 - By Kurt Siggers

 Analysts See $0.01 EPS for CBIZ, Inc. (CBZ)
Investors sentiment is 1.82 in 2017 Q3. Its the same as in 2017Q2. It is the same, as 8 investors sold CBIZ, Inc. shares while 31 reduced holdings. only 17 funds opened positions while 54 raised stakes. 46.06 million shares or 0.80% less from 46.43 million shares in 2017Q2 were reported.
New York-based Fenimore Asset Management Incorporated has invested 0.37% in CBIZ, Inc. (NYSE:CBZ). Dalton Greiner Hartman Maher And has invested 0.14% in CBIZ, Inc. (NYSE:CBZ). Morgan Stanley invested in 148,235 shares. Rhumbline Advisers has invested 0% in CBIZ, Inc. (NYSE:CBZ). Metropolitan Life Ins Co Ny invested in 0% or 35,172 shares. Skyline Asset Mngmt Lp owns 1.36 million shares. Moreover, Art Advsrs Lc has 0.02% invested in CBIZ, Inc. (NYSE:CBZ) for 22,062 shares. State Teachers Retirement owns 4,500 shares for 0% of their portfolio. Boston Prtn has invested 0.01% in CBIZ, Inc. (NYSE:CBZ). Grp Inc owns 34,292 shares or 0% of their US portfolio. Mufg Americas Holdings Corp, New York-based fund reported 564 shares. Citigroup reported 0% of its portfolio in CBIZ, Inc. (NYSE:CBZ). Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in CBIZ, Inc. (NYSE:CBZ). Martingale Asset Management Limited Partnership holds 0.05% or 226,935 shares in its portfolio. Geode Capital Ltd Liability Co holds 468,159 shares.

Since August 31, 2017, it had 0 buys, and 6 selling transactions for $2.20 million activity. 25,000 shares were sold by GROVE WARE H, worth $376,515 on Thursday, August 31. On Tuesday, December 12 Kouzelos Michael P sold $523,250 worth of CBIZ, Inc. (NYSE:CBZ) or 35,000 shares. SPURIO CHRIS sold $246,724 worth of stock.

Analysts expect CBIZ, Inc. (NYSE:CBZ) to report $0.01 EPS on February, 15.They anticipate $0.02 EPS change or 200.00 % from last quarter’s $-0.01 EPS. CBZ’s profit would be $541,050 giving it 415.00 P/E if the $0.01 EPS is correct. After having $0.18 EPS previously, CBIZ, Inc.’s analysts see -94.44 % EPS growth. The stock decreased 0.30% or $0.05 during the last trading session, reaching $16.6. About 37,116 shares traded. CBIZ, Inc. (NYSE:CBZ) has risen 47.49% since January 23, 2017 and is uptrending. It has outperformed by 30.79% the S&P500.

CBIZ, Inc. (NYSE:CBZ) Ratings Coverage

Among 2 analysts covering CBIZ (NYSE:CBZ), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. CBIZ had 6 analyst reports since October 7, 2015 according to SRatingsIntel. Sidoti downgraded the stock to “Neutral” rating in Tuesday, October 13 report. The firm has “Equal-Weight” rating by First Analysis given on Wednesday, October 7. The firm has “Underweight” rating by First Analysis given on Thursday, October 29. The firm earned “Equal-Weight” rating on Tuesday, March 15 by First Analysis. The stock of CBIZ, Inc. (NYSE:CBZ) earned “Buy” rating by Sidoti on Thursday, January 21. The stock has “Buy” rating by Sidoti on Tuesday, July 19.

CBIZ, Inc., through its subsidiaries, provides professional business services, products, and solutions in the United States and Canada. The company has market cap of $898.14 million. It offers its services through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. It has a 20.42 P/E ratio. The Financial Services practice group provides accounting and tax, government health care consulting, financial advisory, valuation, litigation support, risk and advisory, real estate consulting, and internal audit outsourcing services.

More news for CBIZ, Inc. (NYSE:CBZ) were recently published by: Prnewswire.com, which released: “CBIZ To Present At CJS Securities Conference In NYC” on December 27, 2017. Crainscleveland.com‘s article titled: “CBIZ Small Business Employment Index ends the year with a strong December” and published on January 05, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: